SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ImmunityBio converts from Immunomedics
IBRX 2.400+1.7%Oct 31 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
Recommended by:
CCS648
erippetoe
To: galt who wrote (1134)8/15/2025 2:39:57 PM
From: bobbseytwins20012 Recommendations  Read Replies (3) of 1216
 
PSS is the multi-billionaire here in the IBRX story. Not only is he a brilliant scientist, but by earning his billions by selling his biotech babies over the years he has proven ability to deliver the goods, so why should we second guess how he is trying to accomplish his goals here? In addition he has the means to employ others to advise him, and in the long term it has worked out pretty well. This is not Dave Goldenberg we are talking about, but someone who has proven that he is capable of producing outsized returns more than once. And if you are worried about the company not having ample funds we suggest checking the PSS net worth, and acknowledging that he has a lot riding on IBRX. He can get his company to cash flow positive with his checking account balance, but when he decides to move the stock, we think he and his bankers will manage.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext